Navigation Links
Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
Date:8/30/2007

re Test Applications

Nichols Institute also is developing additional ClariSure tests to identify chromosome abnormalities associated with hematological malignancies, such as Leukemia. The ClariSure test is able to detect abnormalities even if cell division has yet to occur, which may enable it to detect abnormalities that suggest the presence of cancer in a higher percentage of patients than is possible using conventional cytogenetic and FISH techniques. The company expects to begin to provide ClariSure assays for hematological malignancies to hospital physicians, including oncologists and hematologists, by the end of this year.

About Mental Retardation

Mental retardation and developmental delay are characterized by significant limitations in intellectual functioning and impaired conceptual and social development. Causes of mental retardation range from chromosome abnormalities to pre-natal environmental conditions. Array CGH techniques will detect chromosome abnormalities in as many as five percent to 17 percent of individuals with mental retardation.(3) With an accurate diagnosis, children are more likely to receive counseling, education and other support appropriate for their condition.

About Quest Diagnostics

Quest Diagnostics is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at http://www.questdiagnostics.com.

This communication contains cert
'/>"/>

SOURCE Quest Diagnostics
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related medicine technology :

1. MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy
2. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
3. To Stent or Not: Is That the Question?
4. Quest PharmaTechs Prostate Cancer Program Update
5. VioQuest Pharmaceuticals Announces Data Presentation for Its Akt Inhibitor VQD-002, at American Association for Cancer Research Annual Meeting
6. Afid Therapeutics Obtains Positive Evaluation of its Triple Mode Viral Sequestration Agents
7. New Advances in Gastric Diagnostics: Smaller is Better
8. West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
9. Researchers Discover Method for Identifying How Cancer Evades the Immune System
10. Controlling the Spread of Healthcare Associated Methicillin Resistant Staphylococcus aureus Requires Active Surveillance
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...December 9 at 11:00 am ET to Discuss Phase 2 Study..., Calif., Dec. 1 Sunes...harmaceutical company focused on the development a... today announced new data from its studies of vore...ented during the 50th American Society of Hematolo...
(Date:12/1/2008)...- Vical Incorporated (Nasdaq: VICL ) announced t...nt from Merck & Co., Inc. based on Merck,s pla...investigational plasmid DNA (pDNA) cancer vaccine....e delivery technology and encodes human telomerase...ct of separate license agreement. , , "The ...
(Date:11/30/2008)... Abnormalities in auditory and language processing... disorder by using magnetoencephalography (MEG), a...meeting of the Radiological Society of North Ameri...e tiny magnetic fields associated with electrical ... chair of research in the Department of Radiology ...
(Date:11/28/2008)...l/ -- Eli Lilly and Company,(NYSE: LLY ) has wi...A) from,the U.S. Food and Drug Administration (FD...ement of chronic pain. Lilly plans to resubmit the...ta from a recently completed positive study,in ch...e decision does not affect duloxetine,s FDA-approv...
Breaking Medicine Technology:Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4UTC Contributes 241 Million to Smilow Cancer Hospital 23698 1UTC Contributes 241 Million to Smilow Cancer Hospital 23698 2Alexion Pharmaceuticals Invites You to Participate in its Second Quarter 2008 Results Conference Call and Web Cast 6484 1Radiation nanotechnology health care and more 3975 1Radiation nanotechnology health care and more 3975 2Radiation nanotechnology health care and more 3975 3Radiation nanotechnology health care and more 3975 4Marteks lifesDHA 28TM 29 Featured in Four New Products from Spectrum Organics 23691 1Marteks lifesDHA 28TM 29 Featured in Four New Products from Spectrum Organics 23691 2Marteks lifesDHA 28TM 29 Featured in Four New Products from Spectrum Organics 23691 3Marteks lifesDHA 28TM 29 Featured in Four New Products from Spectrum Organics 23691 4
...sts Less Abuse-Related Effects For OROS(r),Methylp...efit of Unique OROS(r),Formulation , SAN DIEGO, CA...ngoing concern for parents and physicians who pres...activity Disorder,(ADHD). Data presented on Tuesda...hiatric Association highlighted findings that,long...
....--(BUSINESS WIRE)--May 23, 2007 - Synta,Pharmaceu...ompany,focused on discovering, developing, and com...medical conditions, today announced,that survival ...,trial in metastatic melanoma of the Company,s lea...nted at the annual meeting of the,American Society...
Other Medicine Technology:New Data Focuses on Abuse of Stimulant Medication 2New Data Focuses on Abuse of Stimulant Medication 3New Data Focuses on Abuse of Stimulant Medication 4New Data Focuses on Abuse of Stimulant Medication 5Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 2Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 3
(Date:12/1/2008)...irstCall/ -- Pressure BioSciences, Inc. (Nasdaq: ... comprehensive restructuring program designed to s...ons, and refocus the Company,s business strategy i... found significant market acceptance. The restruc... in personnel of eight full-time employees (40% of...
(Date:12/1/2008)... other special needs, report shows , , M...stic children are more likely to see their sons or...overnment report shows. , Data from the Nation...ds also indicated that when compared with familie...hysical needs, parents caring for autistic childre...
(Date:12/1/2008)...)Concerned that the global financial crisis will l...countries, leaders of the world,s largest agricult...elatively modest, well-targeted investments could ...ons of people living on less than $1 a day. , Sp...roup on International Agricultural Research (CGIAR...
(Date:12/1/2008)...oi:10.1016/j.clim.2008.07.027) published by Elsevi...al journal of the Clinical Immunology Society (CIS...uction of a specific type of immune suppressive ce...se. These immune suppressive cells show great pote... improving transplantation outcomes. , Immunot...
Breaking Medicine News(10 mins):Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 2Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 3Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 4Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 5Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 6Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 7Health News:Health Needs of Autistic Children Often Unmet 2Health News:Health Needs of Autistic Children Often Unmet 3Health News:Experts: Targeted agricultural investments will yield high results, slash poverty in Africa 2Health News:Experts: Targeted agricultural investments will yield high results, slash poverty in Africa 3Health News:Experts: Targeted agricultural investments will yield high results, slash poverty in Africa 4
...ngly certain that the bird flu virus H5N1 will at ...ans , the only uncertainty //being "when?" This wo...d create a scenario like a science fiction film. ...mans got infected through birds, and 148 deaths. ...
...gly, criticized the practice of using duct tape a ...tive lumpy warts //which crop up on skin of hands ...esearchers gathered data which disproves the popul...helpful in some way to hinder the growth of warts ...
...entists, mild electric stimulation of the brain wh... neuroscientist at the University //of Lübeck , Ge...y applied currents that mimic natural slow oscilla...attached to the scalp. 13 medical students who we...
... States, 23.5 million children travel billions of ...or Injury Research and Policy (CIRP) at Columbus//...l sample to describe nonfatal school bus-related i...d in hospital emergency departments across the cou...
Other Medicine News:Health News:Human Strain Of Bird Flu Virus, Just A Matter Of Time? 2Health News:Improved memory with mild electric stimulation 2Health News:Nonfatal School Bus-Related Injuries To Children More Common Than Previously Thought 2
The Finnpipette BioControl multichannel has the same innovative features as the single channel model.The same universal handle fits all seven multichannel and five single channel tip cone modules. Bo
... The new Finnpipette Novus is so user-friendly tha.... With the intuitive instantly familiar menu and s...ing functions you need quickly and easily. The lar...ll names of all functions. The easily accessible ...
...ntire Column of a 384 Well Plate at Once , To inc...es, you need a pipettor that can adapt to the narr...ur 16-channel Impact pipettor., Available with Im...s innovation was specifically designed to allow yo...
The Seal-Away CS and Alliance Catheter Delivery System introducers are designed for the introduction of catheters or devices into the coronary sinus from a superior approach. These introducers combin
Medicine Products: